Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer

被引:69
作者
Jourenkova-Mironova, N
Wikman, H
Bouchardy, C
Voho, A
Dayer, P
Benhamou, S
Hirvonen, A
机构
[1] Inst Gustave Roussy, INSERM 351, Canc Epidemiol Unit, F-94805 Villejuif, France
[2] Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki, Finland
[3] Geneva Canc Registry, Geneva, Switzerland
[4] Univ Hosp Geneva, Div Clin Pharmacol, Geneva, Switzerland
来源
PHARMACOGENETICS | 1998年 / 8卷 / 06期
关键词
lung neoplasms; glutathione transferases; polymorphism; epidemiology;
D O I
10.1097/00008571-199812000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Glutathione S-transferases GSTM1, GSTM3, GSTP1 and GSTT1 are involved in the detoxification of active metabolites of several carcinogens in tobacco smoke, We studied the potential role of GSTM3 and GSTP1 gene polymorphisms either separately, or in combination with GSTM1 and GSTT1 gene polymorphisms, in susceptibility to lung cancer using peripheral blood DNA from 150 lung cancer patients and 172 control individuals, all regular smokers, The frequencies of GSTM3, AA, AB and BB genotypes were 70.7%, 24.0% and 5.3% in cases and 72.7%, 24.4% and 2.9% in control individuals respectively, The frequencies of GSTP1, AA, AG and GG genotypes were 44.7%, 44.0% and 11.3% in cases and 50.0%, 37.2% and 12.8% in control individuals respectively, When studied separately neither GSTM3 nor GSTP1 genotypes contributed significantly to the risk of lung cancer, Although failing to reach statistical significance, the combined GSTM3 AA and GSTP1 (AG or GG) genotype conferred a nearly threefold risk when the GSTM1 gene was concurrently lacking (odds ratio 2.9, 95% confidence interval 0.7-12.1), Significant interactions were observed between pack-years of smelting and the combined GSTM3 AA and GSTP1 (AG or GG) genotype, or the combined GSTM3 AA, GSTP1 (AG or GG) and GSTM1 null genotype, The combination of these three a priori at risk genotypes conferred an increased risk of lung cancer among smokers with a history of at least 35 pack-years (odds ratio 2.7, 95% confidence interval 1.2-6.0), but not in lighter smokers, probable because of the lower average number of pack-years of smelting found among control individuals with this genotype combination. Pharmacogenetics 8:495-502. (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:495 / 502
页数:8
相关论文
共 36 条
[11]   CONJUGATION OF CARCINOGENS BY THETA-CLASS GLUTATHIONE S-TRANSFERASES - MECHANISMS AND RELEVANCE TO VARIATIONS IN HUMAN RISK [J].
GUENGERICH, FP ;
THIER, R ;
PERSMARK, M ;
TAYLOR, JB ;
PEMBLE, SE ;
KETTERER, B .
PHARMACOGENETICS, 1995, 5 :S103-S107
[12]   Allelism at the glutathione S-transferase GSTM3 locus: Interactions with GSTM1 and GSTT1 as risk factors for astrocytoma [J].
Hand, PA ;
Inskip, A ;
Gilford, J ;
Alldersea, J ;
ElexpuruCamiruaga, J ;
Hayes, JD ;
Jones, PW ;
Strange, RC ;
Fryer, AA .
CARCINOGENESIS, 1996, 17 (09) :1919-1922
[13]   Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer [J].
Harries, LW ;
Stubbins, MJ ;
Forman, D ;
Howard, GCW ;
Wolf, CR .
CARCINOGENESIS, 1997, 18 (04) :641-644
[14]   Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients [J].
Harris, MJ ;
Coggan, M ;
Langton, L ;
Wilson, SR ;
Board, PG .
PHARMACOGENETICS, 1998, 8 (01) :27-31
[15]   Combinations of susceptible genotypes and individual responses to toxicants [J].
Hirvonen, A .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 :755-758
[16]   Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders [J].
Hirvonen, A ;
Saarikoski, ST ;
Linnainmaa, K ;
Koskinen, K ;
HusgafvelPursiainen, K ;
Mattson, K ;
Vainio, H .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24) :1853-1856
[17]   THE GSTM1 NULL GENOTYPE AS A POTENTIAL RISK MODIFIER FOR SQUAMOUS-CELL CARCINOMA OF THE LUNG [J].
HIRVONEN, A ;
HUSGAFVELPURSIAINEN, K ;
ANTTILA, S ;
VAINIO, H .
CARCINOGENESIS, 1993, 14 (07) :1479-1481
[18]   Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: Evidence for linkage with GSTM1*A [J].
Inskip, A ;
ElexperuCamiruaga, J ;
Buxton, N ;
Dias, PS ;
MacIntosh, J ;
Campbell, D ;
Jones, PW ;
Yengi, L ;
Talbot, JA ;
Strange, RC ;
Fryer, AA .
BIOCHEMICAL JOURNAL, 1995, 312 :713-716
[19]   Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma [J].
Jahnke, V ;
Strange, R ;
Matthias, C ;
Fryer, A .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1997, 254 (Suppl 1) :S147-S149
[20]   Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers [J].
Jourenkova, N ;
Reinikanen, M ;
Bouchardy, C ;
HusgafvelPursiainen, K ;
Dayer, P ;
Benhamou, S ;
Hirvonen, A .
PHARMACOGENETICS, 1997, 7 (06) :515-518